| Vitamin D, glucose tolerance and insulinaemia in elderly men KCR Baynes, BJ Boucher, EJM Feskens, D Kromhout Diabetologia 40, 344-347, 1997 | 445 | 1997 |
| Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial F D'Aiuto, N Gkranias, D Bhowruth, T Khan, M Orlandi, J Suvan, S Masi, ... The lancet Diabetes & endocrinology 6 (12), 954-965, 2018 | 377 | 2018 |
| Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism F Shojaee-Moradie, KCR Baynes, C Pentecost, JD Bell, EL Thomas, ... Diabetologia 50, 404-413, 2007 | 247 | 2007 |
| Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia TM Tan, BCT Field, KA McCullough, RC Troke, ES Chambers, V Salem, ... Diabetes 62 (4), 1131-1138, 2013 | 236 | 2013 |
| PYY3–36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans BCT Field, AM Wren, V Peters, KCR Baynes, NM Martin, M Patterson, ... Diabetes 59 (7), 1635-1639, 2010 | 139 | 2010 |
| Natural variants of human p85α phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity KCR Baynes, CA Beeton, G Panayotou, R Stein, M Soos, T Hansen, ... Diabetologia 43, 321-331, 2000 | 120 | 2000 |
| Regulation of food intake by gastrointestinal hormones KCR Baynes, WS Dhillo, SR Bloom Current opinion in gastroenterology 22 (6), 626-631, 2006 | 79 | 2006 |
| Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia T Tan, IZ Cabrita, D Hensman, J Grogono, WS Dhillo, KC Baynes, ... Clinical endocrinology 73 (3), 369-374, 2010 | 68 | 2010 |
| Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by … K Dib, JP Whitehead, PJ Humphreys, MA Soos, KC Baynes, S Kumar, ... The Journal of clinical investigation 101 (5), 1111-1120, 1998 | 68 | 1998 |
| Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency C Albrecht, K Baynes, A Sardini, S Schepelmann, ER Eden, SW Davies, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1689 (1), 47-57, 2004 | 41 | 2004 |
| Molecular mechanisms of inherited insulin resistance. KC Baynes, J Whitehead, A Krook, S O'Rahilly QJM: monthly journal of the Association of Physicians 90 (9), 557-562, 1997 | 30 | 1997 |
| Combination of Peptide YY3–36 with GLP-17–36 amide Causes an Increase in First-Phase Insulin Secretion after IV Glucose TM Tan, V Salem, RC Troke, A Alsafi, BCT Field, A De Silva, S Misra, ... The Journal of Clinical Endocrinology & Metabolism 99 (11), E2317-E2324, 2014 | 29 | 2014 |
| The evolving world of GLP-1 agonist therapies for type 2 diabetes KCR Baynes Therapeutic Advances in Endocrinology and Metabolism 1 (2), 61-67, 2010 | 18 | 2010 |
| Association between SGLT2 inhibitor treatment and diabetic ketoacidosis and mortality in people with type 2 diabetes admitted to hospital with COVID-19 K Khunti, Y Ruan, J Davies, BCT Field, S Harris, M Kosiborod, D Nagi, ... Diabetes care 45 (12), 2838-2843, 2022 | 17 | 2022 |
| Selective oestrogen receptor modulators: a new paradigm for HRT KCR Baynes, JE Compston Current Opinion in Obstetrics and Gynecology 10 (3), 189-192, 1998 | 14 | 1998 |
| Hyperprolactinemia in a patient with a pituitary adenoma receiving antipsychotic drug therapy RW Carroll, P Christodoulou, KCR Baynes, DA Kahn Journal of Psychiatric Practice® 18 (2), 126-129, 2012 | 7 | 2012 |
| Artefactually low glycated haemoglobin is a potential pitfall in diabetes management: consider congenital haemolytic anaemias KCR Baynes, C McIntosh, MD Feher Practical Diabetes International 18 (3), 103-106, 2001 | 7 | 2001 |
| Urinary d-lactate as a marker of biochemical dysfunction linked to the development of diabetic microvascular complications N Karachalias, R Babaei-Jadidi, N Ahmed, K Baynes, PJ Thornalley Diabet Med 22 (Suppl 2), 21, 2005 | 6 | 2005 |
| Peri-operative management of patients with diabetes mellitus K Baynes, B Brown, M Feher Current Anaesthesia & Critical Care 12 (3), 172-178, 2001 | 4 | 2001 |
| Indices of beta‐cell function: association with diabetes control in patients with type 2 diabetes on stable GLP‐1 agonist treatment P Behary, IF Godsland, KC Baynes Practical Diabetes 31 (5), 202-205, 2014 | 3 | 2014 |
